ANNOUNCEMENT AstraZeneca completed its acquisition of Alexion, marking the creation of Alexion, AstraZeneca Rare Disease. Inspired Every Day The work we do is guided by people living with rare and devastating diseases. We are driven to continuously innovate and create meaningful value in all we do to help patients and families fully live their best lives. SEE THEIR STORIES TANNER LIVING WITH HPP 1 2 3 4 5 Every day, those who live with rare diseases and devastating conditions inspire us to push the boundaries of medicine, technology, and healthcare services. Our goal is to transform their reality for the better. 5 APPROVED MEDICINES 7 RARE DISEASES & DEVASTATING CONDITIONS 25+ OFFICES WORLDWIDE 3000+ TALENTED COLLEAGUES SEE HOW WE DO IT Everyday Stories FEATURED STORY July 21st marks the beginning of Alexion’s next chapter, with the exciting news that we have been acquired by AstraZeneca, a global, science-led biopharmaceutical company. This development also marks the creation of Alexion, AstraZeneca Rare Disease. Learn More FOLLOW US LATEST NEWS 11/11/21 The Complexity of “Happy Veterans Day” 09/24/21 New Book Series for Children Inspired by Patients 08/02/21 Embedding patient-centricity | LEAP (Learn, Evolve, Activate, and deliver for Patients) MORE NEWS I feel like tomorrow I can do something, whereas before, I didn’t feel like tomorrow was possible.” JESSE LIVING WITH gMG LEARN MORE ABOUT gMG MEDICAL PROFESSIONALS THE RARE DISEASE COMMUNITY INVESTORS JOB SEEKERS Contact Us Legal Statement Privacy Notice Terms of Use Cookies Settings This website is intended only for residents of the United States. © 2021 Alexion Pharmaceuticals, Inc. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Cookies Accept All Cookies